Schedule 13G ownership disclosure

BioLife Solutions Inc

COMMON STOCK · CUSIP: 09062W204

Event date: 2025-06-30

Filing-level shares
4,246,706
Percent of class
8.9%
  • T. Rowe Price Investment Management, Inc.

    Shares: 4,246,706 · Class: 8.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000347
Form type
SCHEDULE 13G
Filer
BIOLIFE SOLUTIONS INC
CIK
CIK 834365
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub